Medical specialists from Germany tagged as investigators in clinical trials studying Leukemia
Total 322 results
-
Georg Heß, PhDSeen in:
- Mainz, Universitatsklinik Mainz
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Georgi Kojouharoff, PhDSeen in:
- Darmstadt, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Gerd Lautenschläger, PhDSeen in:
- Hanau, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Gerhard HeilSeen in:
- Lüdenscheid, DE-Luedenscheid-KLINIKUMLUEDENSCHEID
Trials:- NCT04027309 (Principal Investigator)
-
Gernot Beutel, Dr.Seen in:
- Hannover, Medizinische Hochschule Hannover
- Niedersachsen, Hannover, Medical School Hannover
Trials:- NCT04232241 (Sub-Investigator)
- NCT03662724 (Principal Investigator)
-
Gertrud Lenzen, PhDSeen in:
- Osnabrück, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Gesine Bug, MDSeen in:
- Frankfurt Main, Universitätsklinikum Frankfurt Main, Medical School Frankfurt
- Frankfurt, University Hospital, Medical Department II
Trials:- NCT00199147 (Sub-Investigator)
- NCT02717884 (Sub-Investigator)
Conditions: -
Guido Kobbe, PhDSeen in:
- Düsseldorf, Universitätsklinik Düsseldorf
- NRW, Düsseldorf, Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und Klinische Immunologie
- Nordrhein-Westfalen, Düsseldorf, University Hospital Düsseldorf
Trials:- NCT02131753 (Principal Investigator)
- NCT05675319 (Principal Investigator)
- NCT05807932 (Principal Investigator)
-
Gunnar Cario, Dr.Seen in:
- Kiel, Department of Pediatrics, University Medicine of Schleswig-Holstein, Campus Kiel
- Kiel, UKSH - Universitätsklinikum Schleswig-Holstein, Klinik für Allgemeine Pädiatrie
Trials:- NCT01619124 (Principal Investigator)
- NCT01949129 (Principal Investigator)
Conditions: -
H W Lindemann, PhDSeen in:
- Hagen, St.-Marien-Hospital
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
H Weiss, Prof PhDSeen in:
- Ludwigshafen, St. Marienkrankenhaus
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
H. Müller, Prof. Dr.Seen in:
- Oldenburg, Department of General Pediatrics, Hematology and Oncology Oldenburg gGmbH
Trials:- NCT01619124 (Principal Investigator)
Conditions: -
H.G. DerigsSeen in:
- Frankfurt, DE-Frankfurt-KLINIKUMFRANKFURT
Trials:- NCT04027309 (Principal Investigator)
-
H.J. SalwenderSeen in:
- Hamburg, DE-Hamburg-ASKLEPIOS
Trials:- NCT04027309 (Principal Investigator)
-
Hagen Graf Einsiedel, Dr.Seen in:
- Greifswald, Pediatric Hematology and Oncology, University Medicine Greifswald
Trials:- NCT01619124 (Principal Investigator)
Conditions: -
Hanoun MaherSeen in:
- Essen, Universitaetsklinikum Essen (AoR)
Trials:- NCT04065399 (Principal Investigator)
-
Hans P Laubenstein, PhDSeen in:
- Trier, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Hans-Joachim TischlerSeen in:
- Minden, DE-Minden-MUEHLENKREISKLINKEN
Trials:- NCT04027309 (Principal Investigator)
-
Harald Wagner, PhDSeen in:
- Fürth, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Hartmut Bertz, Prof. Dr.Seen in:
- Freiburg, Universitätsklinikum Freiburg
Trials:- NCT04232241 (Sub-Investigator)
-
Hartmut DöhnerSeen in:
- Ulm, DE-Ulm-UNIKLINKULM
Trials:- NCT04027309 (Principal Investigator)
-
Hedwig Deubzer, MD PhDSeen in:
- Berlin, Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum
Trials:- NCT01949129 (Sub-Investigator)
Conditions: -
Helga BernhardSeen in:
- Darmstadt, DE-Darmstadt-KLINIKUMDARMSTADT
Trials:- NCT04027309 (Principal Investigator)
-
Helmut Oettle, PhDSeen in:
- Friedrichshafen, Community based hemato-oncology medical office
Trials:- NCT02131753 (Principal Investigator)
Conditions: -
Helmut R Salih, MD, Prof.Seen in:
- Tübingen, Tuebingen, Universitätsklinikum Tübingen, Medical School Tuebingen
Trials:- NCT02717884 (Principal Investigator)
Conditions: -
Hendrik PoeckSeen in:
- Regensburg, DE-Regensburg-UKR
Trials:- NCT04027309 (Principal Investigator)
Clinical Trials on Leukemia
-
Massachusetts General HospitalCelgene CorporationTerminatedAcute Myelogenous Leukemia | Acute Myeloid Leukemia (AML) | Acute Myelocytic Leukemia | Acute Granulocytic Leukemia | Acute Non-Lymphocytic LeukemiaUnited States
-
Stanford UniversityTerminatedLeukemia | Leukemia, Lymphocytic, Acute | Leukemia Acute Promyelocytic Leukemia (APL) | Leukemia Acute Lymphoid Leukemia (ALL) | Leukemia Chronic Myelogenous Leukemia (CML) | Leukemia Acute Myeloid Leukemia (AML) | Leukemia Chronic Lymphocytic Leukemia (CLL)United States
-
Institute of Hematology & Blood Diseases HospitalBejing Institute for Stem Cell and Regenerative Medicine; Institute for Stem...RecruitingRefractory Leukemia | Relapsed Leukemia | Acute Myeloid Leukemia, ChildhoodChina
-
Betta Pharmaceuticals Co., Ltd.Not yet recruitingAcute Myeloid Leukemia LeukemiaChina
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditionsUnited States
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedAcute Myelogenous LeukemiaJapan
-
Massachusetts General HospitalCompleted
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia Without Maturation (M1) | Childhood Acute Myelomonocytic Leukemia (M4) | Childhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States